BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 36557997)

  • 1. Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways.
    Qattan MY; Khan MI; Alharbi SH; Verma AK; Al-Saeed FA; Abduallah AM; Al Areefy AA
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways.
    Almatroodi SA; Alsahli MA; Almatroudi A; Verma AK; Aloliqi A; Allemailem KS; Khan AA; Rahmani AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33804548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells.
    Chin HK; Horng CT; Liu YS; Lu CC; Su CY; Chen PS; Chiu HY; Tsai FJ; Shieh PC; Yang JS
    Oncol Rep; 2018 May; 39(5):2351-2357. PubMed ID: 29565448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Properties of Kaempferol on Cellular Signaling Pathways.
    Sengupta B; Biswas P; Roy D; Lovett J; Simington L; Fry DR; Travis K
    Curr Top Med Chem; 2022; 22(30):2474-2482. PubMed ID: 36082856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury.
    Suchal K; Malik S; Gamad N; Malhotra RK; Goyal SN; Chaudhary U; Bhatia J; Ojha S; Arya DS
    Oxid Med Cell Longev; 2016; 2016():7580731. PubMed ID: 27087891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats.
    Suchal K; Malik S; Gamad N; Malhotra RK; Goyal SN; Bhatia J; Arya DS
    Phytomedicine; 2016 Nov; 23(12):1401-1408. PubMed ID: 27765360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaempferol as a therapeutic agent in Alzheimer's disease: Evidence from preclinical studies.
    Dong X; Zhou S; Nao J
    Ageing Res Rev; 2023 Jun; 87():101910. PubMed ID: 36924572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaempferol prevents angiogenesis of rat intestinal microvascular endothelial cells induced by LPS and TNF-α via inhibiting VEGF/Akt/p38 signaling pathways and maintaining gut-vascular barrier integrity.
    Yu R; Zhong J; Zhou Q; Ren W; Liu Z; Bian Y
    Chem Biol Interact; 2022 Oct; 366():110135. PubMed ID: 36049518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis.
    Yao YX; Yu YJ; Dai S; Zhang CY; Xue XY; Zhou ML; Yao CH; Li YX
    Biomed Pharmacother; 2024 Jun; 175():116694. PubMed ID: 38713943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvacrol as a Prospective Regulator of Cancer Targets/Signalling Pathways.
    Singh J; Luqman S; Meena A
    Curr Mol Pharmacol; 2023 Mar; 16(5):542-558. PubMed ID: 35792130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
    Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z
    BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoids and PI3K/Akt/mTOR Signaling Cascade: A Potential Crosstalk in Anticancer Treatment.
    Ul Islam B; Suhail M; Khan MS; Ahmad A; Zughaibi TA; Husain FM; Rehman MT; Tabrez S
    Curr Med Chem; 2021; 28(39):8083-8097. PubMed ID: 34348607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Pharmacology Analysis and Experimental Validation of Kaempferol in the Treatment of Ischemic Stroke by Inhibiting Apoptosis and Regulating Neuroinflammation Involving Neutrophils.
    Zhang SS; Liu M; Liu DN; Shang YF; Du GH; Wang YH
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways.
    Almatroudi A; Allemailem KS; Alwanian WM; Alharbi BF; Alrumaihi F; Khan AA; Almatroodi SA; Rahmani AH
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
    Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z
    Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review.
    Imran M; Rauf A; Shah ZA; Saeed F; Imran A; Arshad MU; Ahmad B; Bawazeer S; Atif M; Peters DG; Mubarak MS
    Phytother Res; 2019 Feb; 33(2):263-275. PubMed ID: 30402931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Potential of Kaempferol, a Flavonoid in the Management of Pathogenesis via Modulation of Inflammation and Other Biological Activities.
    Alrumaihi F; Almatroodi SA; Alharbi HOA; Alwanian WM; Alharbi FA; Almatroudi A; Rahmani AH
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathways.
    Kumar A; Sunita P; Jha S; Pattanayak SP
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):939-50. PubMed ID: 27297262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders.
    Nezhad Salari AM; Rasoulizadeh Z; Shabgah AG; Vakili-Ghartavol R; Sargazi G; Gholizadeh Navashenaq J
    Cell Biochem Funct; 2024 Mar; 42(2):e3964. PubMed ID: 38439154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
    El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
    Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.